Metha® short stem prosthesis 15 years postoperatively -A retrospective clinical and radiological analysis-

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031746

Enrollment

190

Registered

2023-05-08

Start date

2022-07-13

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z96.64

Interventions

Group 1: Patients after hip arthroplasty, with a modular METHA® short stem prosthesis (Aesculap company) in 2005-2006

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients after hip arthroplasty with a modular METHA® short stem prosthesis (Aesculap) from 2005 to 2006

Exclusion criteria

Exclusion criteria: Explantation of the Metha® short stem prosthesis already performed (only the explantation date is recorded here).

Design outcomes

Primary

Measure	Time frame
Data are collected on functionality, satisfaction and pain status. Different standardized scores are queried. - Harris Hip score at personal presentation or modified Harris Hip score at participation by questionnaires - UCLA activity score - WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index)	—

Secondary

Measure	Time frame
Routine radiographs will be used to verify secure prosthesis fit, signs of loosening, and taper condition. In addition, reasons for reoperation of the affected hip joint will be recorded to assess survival of the prosthesis. Patients who do not wish to participate will be asked to indicate if they have had an explantation in order to determine the survival rate as accurately as possible.	—

Countries

Germany

Contacts

Public ContactYvonne Noll

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift

yvonne.noll@diakovere.de+49 511 5354 649

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026